News

The latest advances in echocardiography where discussed at special evening symposium at the 2015 American College of Cardiology (ACC) meeting, organized by Methodist Debakey Heart and Vascular...

A study including more than 20,000 adults in China found combined use of the hypertension medication enalapril and folic acid significantly reduced the risk of first stroke. All of the patients...

SCAI, survey, interventional cardiologists, work injury, orthopedic, radiation

Nearly half of interventional cardiologists responding to a survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) reported at least one work-related orthopedic...

intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective

Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic impact of percutaneous ventricular assist devices (pVAD) with intra-aortic balloon pumps (IABP)...

ORSIF, fluoroscopy, interventional, health risks, awareness

A new non-profit association, the Organization for Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), was recently launched to generate awareness of the potential serious health...

TEE, 3-D TEE, 4-D TEE, GE

Transesophageal echocardiography (TEE) is quickly establishing itself as an essential tool in the interventional cardiologist’s daily toolbox. An alternative to the more traditional...

expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS) devices for treatment of heart failure....

IMRIS, Visius iCT, Health Canada, licensing

IMRIS Inc. announced that Visius iCT, its ceiling-mounted intraoperative computed tomography scanner, has received Health Canada licensing allowing for sales and marketing in the country.

iFR Scout, pullback software, iFR Modality, fractional flow reserve, FFR

Royal Philips announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software. iFR Scout is a functional extension of its existing instant wave-Free Ratio...

The opening session speakers at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will examine the current state of cardiovascular care and why it is...

hospital, stay, heart attack, angioplasty, study

Patients 65 or older discharged from the hospital as early as 48 hours after angioplasty following a major heart attack have similar outcomes as those who stay four to five days, provided...

Virginia Zoo, Sentara Heart Hospital, orangutans, ultrasound

The Virginia Zoo veterinary team partnered with a team from Sentara Heart Hospital to perform ultrasound on the hearts of orangutans Pepper and Schnitz as part of the animals’ annual wellness...

Children's Hospital of Michigan, Ariana Smith, aortic aneurysm, 3-D printing

Seventeen-year-old Ariana Smith recently became the first patient at the Children's Hospital of Michigan, and the first in Michigan, to benefit from a revolutionary 3-D printed heart model to...

Medtronic, CoreValve, Japan, approval, trial

Medtronic announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis (AS). Japanese regulatory authorities granted...

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia...

Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows...

UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality outcomes. The goal of the study was to uncover several trends related to high-...

Corevalve, VIV, valve in valve, FDA

The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have...

The Medicines Company announced that the European Commission has granted marketing authorization for two acute care products – Kengrexal (cangrelor) and Raplixa (sealant powder). These approvals...

ticagrelor, AstraZeneca, FDA, crushing, option

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (...